JRCT ID: jRCT2033240156
Registered date:13/06/2024
Follow-up study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Heart failure with ischemic heart disease |
| Date of first enrollment | 13/06/2024 |
| Target sample size | 10 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | To take immunosuppressant tacrolimus or other immunosuppressant |
Outcome(s)
| Primary Outcome | Safety |
|---|---|
| Secondary Outcome | Safety |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | <= 80age old |
| Gender | Both |
| Include criteria | Subjects who participated in the HS-001-01 study and were transplanted with HS-001CS and who were able to obtain voluntary consent in writing for inclusion in this clinical trial. |
| Exclude criteria | Patients judged by the Investigator to be ineligible shall not be included in the Clinical Trial. |
Related Information
| Primary Sponsor | Kaneko Takehiko |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Madoguchi Toiawase |
| Address | 1-2-3, Shibaura, Minato-ku Tokyo Tokyo Japan 105-0023 |
| Telephone | +81-3-6380-1068 |
| chiken@heartseed.jp | |
| Affiliation | Heartseed Inc |
| Scientific contact | |
| Name | Takehiko Kaneko |
| Address | 1-2-3, Shibaura, Minato-ku Tokyo Tokyo Japan 105-0023 |
| Telephone | +81-3-6380-1068 |
| chiken@heartseed.jp | |
| Affiliation | Heartseed Inc |